Ultra-Myossage Lotion 1-gallon bottle, REF: 4262; Myossage Lotion 1-gallon bottle, REF: 4210, lo...

FDA Device Recall #Z-0010-2022 — Class I — September 7, 2021

Recall Summary

Recall Number Z-0010-2022
Classification Class I — Serious risk
Date Initiated September 7, 2021
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm DJO, LLC
Location Carlsbad, CA
Product Type Devices
Quantity 8,702

Product Description

Ultra-Myossage Lotion 1-gallon bottle, REF: 4262; Myossage Lotion 1-gallon bottle, REF: 4210, located in the following DJO, LLC / DJO FRANCE kits:

Reason for Recall

Ultrasound gels and lotions manufactured by Eco-Med Pharmaceutical, Inc. may contain bacterial contamination. On August 18, 2021, FDA published a Letter to Health Care Providers to further address this issue: https://www.fda.gov/medical-devices/letters-health-care-providers/stop-using-all-eco-med-ultrasound-gels-and-lotions-due-risk-bacterial-contamination-letter-health.

Distribution Pattern

Worldwide distribution - U.S. Nationwide distribution including in the states of ND, NJ, CO, HI, CA, MA, FL, GA, IN, WA, NY, TX, IA, TN, NV, LA, CT, VA, NC, WI, MS, OR, MI, AL, MN, VT, IL, OH, AR, NM, DE, PA, SC, AZ, MD, RI, KY, UT, MO, OK, MT, ID, NE, WY, ME, WV, SD, KS, PR, NH, DC, AK, VI and the countries of France, China, Mexico, Ontario, Australia.

Lot / Code Information

All Lots manufactured by Eco-Med Pharmaceutical, Inc

Other Recalls from DJO, LLC

Recall # Classification Product Date
Z-0722-2026 Class II Cold Form Wrap: Back, REF: DP163CT03-BLK-L,XL, ... Sep 25, 2025
Z-0009-2022 Class I GEL CONDUCTOR, Description/REF: 5 LITER W/DISP/... Sep 7, 2021
Z-1985-2019 Class II Aircast REF 3011 - PL RX only VF-PL Sterile Cuf... Jan 17, 2019
Z-2590-2020 Class II This is an accessory to Intelect Advanced, Inte... Jun 25, 2018
Z-0121-2016 Class II Monode, Shortwave Accessory Model #: 02200002 ... Aug 21, 2015

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.